IGeneX was founded in 1991 by Dr. Nick Harris, a leading pioneer in Lyme disease diagnostics, following 3M's sale of its Diagnostics Division. Recognizing the urgent need for more sensitive and accurate Lyme disease tests, Dr. Harris assembled a team dedicated to advancing the scientific diagnosis of tick-borne diseases. His groundbreaking laboratory testing introduced new diagnostic tools that significantly improved physicians' ability to diagnose and treat these often debilitating conditions.

Dr. Harris was also a key figure in the formation of the International Lyme and Associated Diseases Society (ILADS), an organization that trains physicians to recognize and treat tick-borne diseases and become Lyme-literate. His work with ILADS helped ensure that future generations of physicians would have the knowledge and tools needed to care for patients suffering from these complex conditions.

IGeneX continues Dr. Harris’s mission to improve testing for tick-borne diseases. The lab now offers an expanded menu of tests for Lyme disease, Tick-Borne Relapsing Fever, Bartonella, Babesia, Rickettsia, Anaplasma, and Ehrlichia, utilizing advanced diagnostic methods such as ImmunoBlots, Western blots, PCR, FISH, IFA, and IgXSpot.

With a commitment to innovation, IGeneX reinvests 15 to 20 percent of its net profits into research and development, ensuring continuous improvement in the accuracy and sensitivity of its diagnostic tools. This focus on advancement allows IGeneX to detect tick-borne pathogens more effectively, regardless of when exposure occurred, helping to lead the industry in patient care and diagnosis.

Overcoming Lyme Disease and Babesia:
The Story of IGeneX Patient Lucy

As a star soccer player and budding teenager, Lucy had always been very active and full of energy. Then her parents noticed a change. She stopped running fast on the field and would come home from school and go to sleep. They wondered if it was just a phase, or something worse. Hear how testing from IGeneX provided the family with the answers